ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 2.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $713,000 | -70.0% | 57,340 | -66.9% | 0.00% | -72.7% |
| Q3 2016 | $2,375,000 | +290.0% | 173,410 | +110.5% | 0.01% | +266.7% |
| Q2 2016 | $609,000 | -0.3% | 82,366 | -21.3% | 0.00% | -25.0% |
| Q3 2015 | $611,000 | -68.7% | 104,652 | -55.7% | 0.00% | -66.7% |
| Q2 2015 | $1,952,000 | +39.9% | 236,101 | +39.4% | 0.01% | +9.1% |
| Q1 2015 | $1,395,000 | +103.6% | 169,368 | +69.7% | 0.01% | +83.3% |
| Q4 2014 | $685,000 | +341.9% | 99,800 | +311.4% | 0.01% | +200.0% |
| Q2 2014 | $155,000 | -83.3% | 24,259 | -79.0% | 0.00% | -80.0% |
| Q1 2014 | $930,000 | – | 115,442 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |